Novel combinations and targeted pathway inhibitors may improve adherence and blood pressure control in patients with ...

Despite the availability of effective antihypertensive therapies, global blood pressure control rates remain unacceptably low. Contributing factors, such as low treatment adherence, therapeutic ...

The human body is often described in parts—different limbs, systems, and organs—rather than something fully interconnected and whole. Yet many bodily processes interact in ways we may not always ...

Hypertension is one of the most common chronic conditions in the U.S., affecting nearly half of the country’s adults, according to the Centers for Disease Control and Prevention. Unfortunately, ...

The "silent killer" may finally meet a powerful new shield marking a seismic shift in cardiology —one injection that protects for six months at a time.

The development, researchers say, could fundamentally change how hypertension is managed, particularly at a time when control rates remain alarmingly low.

Idiopathic intracranial hypertension, also called pseudotumor cerebri, refers to elevated cerebrospinal fluid (CSF) pressure that develops most often in women of reproductive age with obesity, causing ...

Hypertension may be silent, but its consequences are not. Early detection and timely treatment can prevent heart attacks, strokes, and kidney failure. As the country observes Philippine Heart Month, ...

Diagnostic delays in hypertension lead to lower treatment rates and increased cardiovascular risk, with prescription rates decreasing as delays lengthen. Delayed diagnoses correlate with a higher risk ...